v3.21.2
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities:    
Net loss $ (11,241,425) $ (6,452,966)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 1,406,936 930,443
Depreciation 9,577 7,952
Changes in operating assets and liabilities:    
Prepaid expenses (1,373,257) (556,457)
Accounts payable 515,244 6,515
Accounts payable and accrued expenses - related party 0 (45,833)
Accrued expenses 381,418 239,101
Net cash used in operating activities (10,301,507) (5,871,245)
Cash Flows from Investing Activities:    
Purchase of property and equipment (3,672) (17,945)
Net cash used in investing activities (3,672) (17,945)
Cash Flows from Financing Activities:    
Payment of deferred offering cost 0 (45,000)
Payments on notes payable (394,662) 0
Proceeds from exercise of warrants 332,750 0
Proceeds from sale of common stock, net 4,653,821 0
Net cash provided by (used in) financing activities 4,591,909 (45,000)
Net change in cash and cash equivalents (5,713,270) (5,934,190)
Cash and cash equivalents, at beginning of period 14,039,493 7,241,288
Cash and cash equivalents, at end of period 8,326,223 1,307,098
Supplemental disclosures of cash flow information:    
Cash paid for interest 7,207 0
Cash paid for income taxes 0 0
Supplemental disclosure of non-cash investing and financing activities:    
Cashless exercise of warrants 1,296 0
Common stock issued for deferred offering costs $ 0 $ 395,902

Source